Results 231 to 240 of about 482,957 (287)

Cardioprotective effects of acetate supplementation against fructose-induced cardiac injury in pregnant Wistar rats. [PDF]

Curr Res Physiol
Oyabambi AO, Agbaraolorunpo FM, Oguntebi EE, Oyakojo BC, Abena E.   +4 more
europepmc   +1 more source

Utilization of immune checkpoint inhibitors for the treatment of cancer in Scotland, 2018–2024: A national retrospective cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aims The aim of the study is to describe the use of immune checkpoint inhibitors (ICIs) for the treatment of cancer in Scotland. Methods The retrospective observational cohort study included patients aged 18 years or older who commenced treatment with an ICI in Scotland between 1 January 2018 and 31 December 2024.
Tanja Mueller, Christine Crearie, Liya Lu, Jiafeng Pan, Fraser N. Sneden, David Martin, Amanj Kurdi, Catherine S. Thomson, Julie Clarke, Marion Bennie   +9 more
wiley   +1 more source

Disseminated Tumor Cells (DTCs) in Patients with Cervical Cancer Reveal Mesenchymal Properties and Potential Therapeutic Targets-A New Perspective? [PDF]

Int J Mol Sci
Brochwitz E, Nel I, Eckardt A, Weydandt L, Höhn AK, Winter K, Aktas B.   +6 more
europepmc   +1 more source

Anti-vascular endothelial growth factor therapy for posterior segment diseases: Progress, challenges, and the road ahead. [PDF]

Indian J Ophthalmol
Mishra C, Mohanty N, Purohit S, Orugonda U, Patil V.   +4 more
europepmc   +1 more source

Neovascular glaucoma: pathophysiology, diagnosis, and contemporary management. [PDF]

Front Med (Lausanne)
Yu D, Cui C, Li G, Wang Z.
europepmc   +1 more source

Analysis of the therapeutic effects of anti-vascular endothelial growth factor treatment based on indocyanine green angiographic staining patterns in patients with central serous chorioretinopathy. [PDF]

Indian J Ophthalmol
Hwang BE, Kim M, Park YG, Park YH.
europepmc   +1 more source

Non-intravitreal anti-vascular endothelial growth factor delivery for ocular neovascular diseases: Current status and future directions. [PDF]

Indian J Ophthalmol
Joshi SM, Vibhute G, Rao SM, Ayachit A, Ayachit G.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Molecular mechanism of VEGF and its role in pathological angiogenesis

Journal of Cellular Biochemistry, 2022
Over the last seven decades, a significant scientific contribution took place in the delineation of the implications of vascular endothelial‐derived growth factor (VEGF) in the processes of angiogenesis.
A. Ahmad, M. Nawaz
semanticscholar   +1 more source

Novel VEGF family members: VEGF-B, VEGF-C and VEGF-D

The International Journal of Biochemistry & Cell Biology, 2001
Vascular endothelial growth factors (VEGFs) constitute a group of structurally and functionally related growth factors that modulate many important physiological functions of endothelial cells. Currently, five different mammalian VEGFs have been identified and they all show unique temporal and spatial expression patterns, receptor specificity and ...
X, Li, U, Eriksson
openaire   +2 more sources

VEGF antagonists

Expert Opinion on Biological Therapy, 2001
The majority of cancer have an absolute requirement for angiogenesis, the process by which new blood vessels are formed. The most potent angiogenic cytokine is vascular endothelial growth factor (VEGF) and there has been substantial research into the development of VEGF/VEGF receptor (VEGFR) antagonists.
Hasan, J, Jayson, G; id_orcid 0000-0002-8515-8944   +1 more
openaire   +3 more sources